INKON Life Technology Co., Ltd. (SHE:300143)

China flag China · Delayed Price · Currency is CNY
11.92
-0.03 (-0.25%)
Jan 22, 2026, 4:00 PM EST
37.64%
Market Cap9.01B
Revenue (ttm)1.69B
Net Income (ttm)119.72M
Shares Out743.29M
EPS (ttm)0.17
PE Ratio73.10
Forward PE65.51
Dividendn/a
Ex-Dividend Daten/a
Volume11,576,165
Average Volume27,041,101
Open12.04
Previous Close11.95
Day's Range11.79 - 12.08
52-Week Range8.12 - 14.38
Beta0.80
RSI59.49
Earnings DateMar 28, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was fo... [Read more]

Sector Healthcare
Founded 1998
Employees 2,207
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300143
Full Company Profile

Financial Performance

In 2024, INKON Life Technology's revenue was 1.56 billion, an increase of 6.01% compared to the previous year's 1.47 billion. Earnings were 115.42 million, an increase of 14.92%.

Financial Statements